NDAQ:VERU - Post Discussion
Veru Inc
> Veru Enrolls First Patients in Phase 2b Clinical Trial of En
Post by
whytestocks on Apr 30, 2024 12:15pm
Veru Enrolls First Patients in Phase 2b Clinical Trial of En
BREAKING NEWS: $VERU Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss-- The Phase 2b study planned to be conducted in 15 clinical sites in the United States -- -- Topline clinical data expected in the fourth quarter calendar year 2024 -- MIAMI, FL, April 30, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical ...
VERU - Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Be the first to comment on this post